These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 15713554

  • 1. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G, Martin J, Chumakov K.
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [Abstract] [Full Text] [Related]

  • 2. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
    Rezapkin G, Dragunsky E, Chumakov K.
    Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
    [Abstract] [Full Text] [Related]

  • 3. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
    Tano Y, Shimizu H, Martin J, Nishimura Y, Simizu B, Miyamura T.
    Vaccine; 2007 Oct 10; 25(41):7041-6. PubMed ID: 17825459
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.
    Sawyer LA, Wood D, Ferguson M, Crainic R, Beuvery EC, McInnis J, Albrecht P.
    Biologicals; 1997 Sep 10; 25(3):299-306. PubMed ID: 9324998
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM, Ivanov AP, Wells VR, Ivshina AV, Rezapkin GV, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM.
    J Infect Dis; 2004 Oct 15; 190(8):1404-12. PubMed ID: 15378432
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP, Nikolaienko IV, Kopanytsia LV, Solohub VK, Ivanova OIe.
    Mikrobiol Z; 1997 Oct 15; 59(6):27-36. PubMed ID: 9511373
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
    Doi Y, Abe S, Yamamoto H, Horie H, Ohyama H, Satoh K, Tano Y, Ota Y, Miyazawa M, Wakabayashi K, Hashizume S.
    Dev Biol (Basel); 2001 Oct 15; 105():163-9. PubMed ID: 11763324
    [Abstract] [Full Text] [Related]

  • 18. Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines.
    Westdijk J, Brugmans D, Martin J, van't Oever A, Bakker WA, Levels L, Kersten G.
    Vaccine; 2011 Apr 18; 29(18):3390-7. PubMed ID: 21397718
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Evaluation of an ELISA kit made in our laboratory for intratypic discrimination of poliovirus type 1 strains isolated from acute flask paralysis].
    Ozkaya E, Arita M.
    Mikrobiyol Bul; 2002 Jan 18; 36(1):71-7. PubMed ID: 12476769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.